Showing results (271-280 of 295) with videos related to
Sort By:
Pageof 30
The Journal of Biological Chemistry|August 12, 2004
Structural analysis of the complement control protein (CCP) modules of GABA(B) receptor 1a: only one of the two CCP modules is compactly foldedStanislas Blein, Rachel Ginham, Dusan Uhrin, et al.Human Molecular Genetics|January 4, 2007
SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinAChristopher T Esapa, Adrian Waite, Matthew Locke, et al.Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|August 6, 2021
Accuracy of a rapid glial fibrillary acidic protein/ubiquitin carboxyl-terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injuryJeffrey J Bazarian, Robert D Welch, Krista Caudle, et al.The Journal of Infectious Diseases|November 18, 2021
Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed IndividualsAi-Ris Y Collier, Jingyou Yu, Katherine McMahan, et al.Gastroenterology|October 12, 2014
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantationMichael Charlton, Edward Gane, Michael P Manns, et al.The Journal of Biological Chemistry|February 22, 2007
Actin-binding protein alpha-actinin-1 interacts with the metabotropic glutamate receptor type 5b and modulates the cell surface expression and function of the receptorNuria Cabello, Rosaria Remelli, Laia Canela, et al.Clinical Transplantation|February 9, 2016
Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter studyJessica L Mueller, Lindsay Y King, Kara B Johnson, et al.The Lancet. Gastroenterology & Hepatology|June 4, 2018
Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1Marc Bourlière, Stuart C Gordon, Eugene R Schiff, et al.Gastroenterology|September 28, 2014
Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label studyMichael P Curry, Xavier Forns, Raymond T Chung, et al.Transplantation|June 14, 2008
Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantationKaren J Ho, Christopher D Owens, Scott R Johnson, et al.Pageof 30